Coordinated selling by multiple top executives, including the CEO, may signal lack of confidence in near-term prospects. Traders should monitor for absence of positive catalysts or potential downside risks ahead of next earnings or clinical updates.
Price Chart
Executive Summary
Four C-suite executives at Vera Therapeutics — including CEO Fordyce Marshall — sold shares in a coordinated open-market transaction on February 23, 2026, totaling approximately $977,000 in value. All sales were conducted at the same price, indicating a planned divestment during a single trading day.
Key Financial Metrics
Key Facts
- CEO Fordyce Marshall sold 16,925 shares for $710,577.51 in open-market transaction.
- Three other C-suite officers (Chief Regulatory, Chief Operating, and Chief Commercial Officers) collectively sold 6,348 shares for $266,514.78.
- All transactions occurred on the same day at the same price ($41.9839), suggesting coordination.
- Total insider selling cluster value: $977,092.29 in open-market sales.
Financial Impact
$977,092 in open-market share sales by C-suite executives
Risk Factors
- Perception of insider pessimism could pressure share price.
- Lack of offsetting insider buying increases net negative sentiment.
- Possible upcoming negative developments in clinical programs or funding outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-VERA-1772067545581 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access